Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Actinomycin-D from Rasna Therapeutics will expand Tiziana Life Sciences's pipeline. The drug is on the WHO's List of Essential Medicines as the most effective medicines needed in a health system.
Lead Product(s): Dactinomycin
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Large molecule
Partner/Sponsor/Collaborator: Tiziana Life Sciences
Deal Size: $0.6 million Upfront Cash: $0.1 million
Deal Type: Acquisition April 24, 2020